|
|
|
|
|
The regulation and mechanism of autophagy on endothelial-to-mensenchymal transition and cardiac fibrosis after acute myocardial infarction |
Zou Jin, Yang Qin, Li Bin-gong, Ke Xuan, Hao Yan-qin, Li Xue-lian, Li Xing-xing |
Department of Cardiology, the First Affiliated Hospital, Nanchang University, Nanchang 330006, China |
|
|
Abstract Objective To detect the feasibility of intervening autophagy ameliorates cardiac fibrosis via inhibiting endothelial-to-mesenchymal transition(EndMT) after acute myocardial infarction (AMI). Methods SD rats were randomly divided into 4 groups: Sham group(n=15),AMI group(n=16), AMI+rapamycin group(n=15), and AMI+3-MA group(n=14). Intervening the levels of autophagy by injecting SD rats intraperitoneally after MI. Echocardiography was performed to assess LVEF, LVFS, LVIDd and LVIDs. Masson′s trichrome was performed to assess cardiac fibrosis and collagen volume fraction (CVF) was analyzed. The expressions of CD31, α-SMA, COL1, LC3 and Belin1 in the infarct border zone were examined by Western blot. Double immunofluorescence staining was used to detect the CD31+α-SMA+ cells undergoing EndMT and the changes of LC3 in endothelial cells the infarction border zone. Results Compared with the AMI group, rapamycin treatment increased EF and FS, decreased LVIDd, LVIDs and CVF (P<0.05); 3-MA treatment increased CVF (P<0.05), but had no obvious effect on improving cardiac function after myocardial infarction. LC3-II increased significantly within 1 day after AMI, lasting 1~2 days, and then decreased gradually (P<0.05). At the 7th day after AMI, CD31 was downregulated, ɑ-SMA and COL1 were upregulated and the number of CD31+ɑ-SMA+ cells increased in cardiac tissue sections (P<0.05), but LC3 and Beclin1 did not change significantly. Compared with the AMI group, the expression of LC3-II, Beclin1 and CD31 in the AMI+RAP group increased, the expression of ɑ-SMA and COL1 and the number of CD31+ɑ-SMA+ cells decreased (P<0.05). But these treds was reversed in the AMI+ 3-MA group (P<0.05). Conclusion EndMT contributes to cardiac fibrosis post-MI. Enhanced autophagy inhibits EndMT, attenuates cardiac fibrosis and dysfunction.
|
|
Corresponding Authors:
Li Bin-gong, E-mail: libingong08@163.com
|
|
|
|
[1]中国心血管病报告编写组.《中国心血管病报告2016》概要[J]. 中国循环杂志, 2017, 32(6):521-530.
[2]王冰,李良海,金平,等.橙皮素干预改善小鼠心肌梗死后心室重构及心功能[J]. 中华急诊医学杂志, 2017, 26(7): 739-744.
[3]Xu L, Yates CC, Lockyer P, et al. MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition[J]. J Mol Cell Cardiol, 2014, 77: 86-101.
[4]Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis[J]. Nat Med, 2007, 13(8): 952-961.
[5]Zhang H, Hui H, Li Z, et al. Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction[J]. Sci Rep, 2017, 7: 41 932.
[6]Widyantoro B, Emoto N, Nakayama K, et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition[J]. Circulation, 2010, 121(22): 2407-2418.
[7]Zou M, Wang F, Gao R, et al. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-beta R Ⅱ during TGF-beta1-induced fibrogenesis in human cardiac fibroblasts[J]. Sci Rep, 2016, 6:24 747.
[8]Li S, Liu C, Gu L, et al. Autophagy protects cardiomyocytes from the myocardial ischaemia-reperfusion injury through the clearance of CLP36[J]. Open Biol, 2016, 6(8):160 177.
[9]Bhuiyan MS, Pattison JS, Osinska H, et al. Enhanced autophagy ameliorates cardiac proteinopathy[J]. J Clin Invest, 2013, 123(12): 5284-5297.
[10]Aisagbonhi O, Rai M, Ryzhov S, et al. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition[J]. Dis Model Mech, 2011, 4(4): 469-483.
[11]Piek A, de Boer RA, Silljé HH. The fibrosis-cell death axis in heart failure[J]. Heart Fail Rev, 2016, 21(2): 199-211.
[12]van Putten S, Shafieyan Y, Hinz B. Mechanical control of cardiac myofibroblasts[J]. J Mol Cell Cardiol, 2016, 93: 133-142.
[13]田晋帆,葛长江,吕树铮,等.心肌纤维化发病机制及其防治研究进展[J]. 中国医药, 2013, 8(5): 602-604.
[14]Shirakabe A, Ikeda Y, Sciarretta S, et al. Aging and Autophagy in the Heart[J]. Circ Res, 2016, 118(10): 1563-1576.
[15]Yan CH, Li Y, Tian XX, et al. CREG1 ameliorates myocardial fibrosis associated with autophagy activation and Rab7 expression[J]. Biochim Biophys Acta, 2015, 1852(2): 353-364.
[16]Mario G, Pietrocola F, Kong Y, et al. Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy[J]. Autophagy, 2014, 10(5):930-932.
[17]Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress[J]. Nat Med, 2007, 13(5):619-624.
[18]Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress[J]. J Clin Invest, 2007, 117(7): 1782-1793.
[19]Wu X, He L, Chen F, et al. Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction[J]. PLoS One, 2014, 9(11): e112 891. |
|
|
|